array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Natus Medical Incorporated"
["slug"]=>
string(35) "05e48-us-natus-medical-incorporated"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a"
["description"]=>
string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status."
["address_street"]=>
string(29) "6701 Koll Center Pkwy Ste 120"
["address_place"]=>
string(10) "Pleasanton"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1987-02-13"
["website_domain"]=>
string(9) "natus.com"
["website_url"]=>
string(17) "https://natus.com"
["industry_codes"]=>
array(1) {
[0]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(1480)
["article_count"]=>
int(148)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(60) "Natus Medical Announces First Quarter 2022 Financial Results"
["snippet_en"]=>
string(154) "Q1-2022 Key ResultsRevenue (millions)$119.8 • Total revenue increased 4.2% compared to Q1 2021• Generated $8.9 million in operating cash flowGAAP..."
["url"]=>
string(139) "https://www.globenewswire.com/en/news-release/2022/05/05/2437257/31146/en/Natus-Medical-Announces-First-Quarter-2022-Financial-Results.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fc44fb09-0509-4bc7-9852-311382a64505"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2022-05-05"
["categories"]=>
array(2) {
[0]=>
string(25) "Start-up's & New Business"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[1]=>
array(7) {
["title_en"]=>
string(68) "Natus Medical beats the Street in Q4, announces business realignment"
["snippet_en"]=>
string(113) "Natus Medical (NSDQ:NTUS) this week posted fourth-quarter results that beat the overall consensus on Wall Street."
["url"]=>
string(100) "https://www.massdevice.com/natus-medical-beats-the-street-in-q4-announces-realignment-of-businesses/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7758b49e-2584-4b29-9d16-89bc52982dc7"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2022-02-25"
["categories"]=>
array(2) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(12) "Stock Market"
}
}
[2]=>
array(7) {
["title_en"]=>
string(51) "Natus Medical slides on missed earnings projections"
["snippet_en"]=>
string(250) "Natus Medical (NSDQ:NTUS) shares took a hit today on second-quarter results that came up short of the consensus earnings forecast. The Pleasanton, Calif.-based maker of monitoring and diagnostics for newborns posted losses of-$ 8.9 million, or -26¢"
["url"]=>
string(79) "https://www.massdevice.com/natus-medical-slides-on-missed-earnings-projections/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5f3e0bac-0205-4c28-b371-5b9366560e5f"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2020-08-03"
["categories"]=>
array(2) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
}
}
[3]=>
array(7) {
["title_en"]=>
string(174) "Amid the COVID-19 crisis and the looming economic recession, the Brain Monitoring Devices market worldwide will grow by a projected US$2.9 Billion, during the analysis period"
["snippet_en"]=>
string(66) "driven by a revised compounded annual growth rate (CAGR) of 4. 4%."
["url"]=>
string(244) "https://www.globenewswire.com/news-release/2020/06/04/2043921/0/en/Amid-the-COVID-19-crisis-and-the-looming-economic-recession-the-Brain-Monitoring-Devices-market-worldwide-will-grow-by-a-projected-US-2-9-Billion-during-the-analysis-period.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4015f023-bd0b-493f-85a8-46d8f57ec733"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2020-06-04"
["categories"]=>
array(4) {
[0]=>
string(8) "Epidemic"
[1]=>
string(24) "Systemic Risk Management"
[2]=>
string(24) "Quarterly/Annual Figures"
[3]=>
string(19) "Economic Conditions"
}
}
[4]=>
array(7) {
["title_en"]=>
string(40) "Natus Medical gains on Q3 swing to black"
["snippet_en"]=>
string(181) "Natus Medical (NSDQ:NTUS) swung from red to black with its third-quarter results and raised its earnings outlook for the rest of the year, sending its share price up on Wall Street."
["url"]=>
string(68) "https://www.massdevice.com/natus-medical-gains-on-q3-swing-to-black/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c929e762-681b-4907-b741-2e5069c8de64"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2019-10-28"
["categories"]=>
array(3) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
}
}
[5]=>
array(7) {
["title_en"]=>
string(38) "Natus shares rise on Street-topping Q1"
["snippet_en"]=>
string(250) "Shares in Natus Medical (NSDQ:BABY) have risen slightly in after hours trading after the medical device maker posted first quarter earnings that topped expectations on Wall Street. The Pleasanton, Calif.-based company posted losses of approximately$"
["url"]=>
string(66) "https://www.massdevice.com/natus-shares-rise-on-street-topping-q1/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/aed763bc-f310-4ee8-988f-75d29f254f2c"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2019-04-25"
["categories"]=>
array(3) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(161) "NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm"
["snippet_en"]=>
string(150) "Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated (“Natus” or the"
["url"]=>
string(106) "https://www.businesswire.com/news/home/20190326005991/en/NATUS-INVESTOR-ALERT-Faruqi-Faruqi-LLP-Encourages"
["image_url"]=>
NULL
["source"]=>
string(16) "businesswire.com"
["publication_date"]=>
string(10) "2019-03-26"
["categories"]=>
array(2) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(10) "Litigation"
}
}
[7]=>
array(7) {
["title_en"]=>
string(161) "NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm"
["snippet_en"]=>
string(161) "/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or..."
["url"]=>
string(213) "https://www.prnewswire.com/news-releases/natus-investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-exceeding-50-000-investing-in-natus-medical-incorporated-to-contact-the-firm-300803452.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/005abbc1-097c-4bb9-9cdb-cf5d9b7f38af"
["source"]=>
string(14) "prnewswire.com"
["publication_date"]=>
string(10) "2019-02-27"
["categories"]=>
array(3) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(18) "General Investment"
[2]=>
string(10) "Litigation"
}
}
[8]=>
array(7) {
["title_en"]=>
string(49) "Natus Medical Inc. Fell 11% in April. Here's Why."
["snippet_en"]=>
string(84) "A bottom-line contraction in the first quarter isn't what the market wanted to hear."
["url"]=>
string(76) "https://foxbusiness.com/markets/natus-medical-inc-fell-11-in-april-heres-why"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0d3af3fb-b020-4fda-bfa4-94ead1a125e3"
["source"]=>
string(15) "foxbusiness.com"
["publication_date"]=>
string(10) "2017-05-08"
["categories"]=>
array(2) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(12) "Stock Market"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(23)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(12)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(11)
}
[3]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[4]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(5)
}
[6]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(4)
}
[9]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(3)
}
[10]=>
array(2) {
["name"]=>
string(5) "SPACs"
["count"]=>
int(3)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(3)
}
[12]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(3)
}
[13]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(3)
}
[14]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(2)
}
[16]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[17]=>
array(2) {
["name"]=>
string(10) "Downsizing"
["count"]=>
int(2)
}
[18]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(2)
}
[19]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(2)
}
[20]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(2)
}
[21]=>
array(2) {
["name"]=>
string(22) "Shareholder Reputation"
["count"]=>
int(2)
}
[22]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(2)
}
[23]=>
array(2) {
["name"]=>
string(5) "Fraud"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(10) "Complaints"
["count"]=>
int(1)
}
}
}
05e48-us-natus-medical-incorporated
Natus Medical Incorporated
Location
California
Founded
1987-02-13
Website
https://natus.com
Articles
148 Articles
Category
Electromedical and Electrotherapeutic Apparatus
Description
Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status.
Natus Medical (NSDQ:NTUS) shares took a hit today on second-quarter results that came up short of the consensus earnings forecast. The Pleasanton, Calif.-based maker of monitoring and diagnostics for newborns posted losses of-$ 8.9 million, or -26¢
Natus Medical (NSDQ:NTUS) swung from red to black with its third-quarter results and raised its earnings outlook for the rest of the year, sending its share price up on Wall Street.
Shares in Natus Medical (NSDQ:BABY) have risen slightly in after hours trading after the medical device maker posted first quarter earnings that topped expectations on Wall Street. The Pleasanton, Calif.-based company posted losses of approximately$
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
